Azatadine
 | |
| Clinical data | |
|---|---|
| Trade names | Optimine |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H22N2 |
| Molar mass | 290.402 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Azatadine (Optimine) is a first-generation antihistamine and anticholinergic that was launched Schering-Plough in 1973.[1][2][3]
It was patented in 1967.[4]
- It is a predecessor to loratidine, albeit lacking the chlorine atom. Also, it is N-methyl instead of carboethoxyamido.
See also
References
- ↑ PMID 8795241 (PMID 8795241)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 1982614 (PMID 1982614)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 1968324 (PMID 1968324)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Azatadine, Villani, F. J.; Caldwell, W. U.S. Patent 3,326,924 (1967).